(XMTR) Xometry - NASDAQ
Sector: Industrials | Industry: Industrial Distribution | Exchange: NASDAQ (USA) | Market Cap: 4.456m USD | Total Return: 154.7% in 12m
Avg Turnover: 69.4M
Qual. Beats: 2
Rev. Trend: 99.6%
Qual. Beats: 5
Warnings
Interest Coverage Ratio -9.9 is critical
Altman Z'' -0.31 < 1.0 - financial distress zone
Tailwinds
Rs Leader, Idiosyncratic Leader, Tailwind, Pullback 52w, Confidence
Xometry, Inc. (XMTR) operates an AI-driven marketplace that connects enterprise buyers with a global network of manufacturing service providers. The platform utilizes a proprietary instant quoting engine to automate pricing and lead times for custom-manufactured parts, including CNC machining, 3D printing, and injection molding. Through its acquisition of Thomasnet, the company also provides industrial sourcing data and digital marketing services to manufacturers.
The business model functions as a two-sided marketplace, reducing procurement friction in the highly fragmented $2 trillion global manufacturing market. By leveraging machine learning, Xometry aggregates demand and optimizes capacity utilization for small-to-mid-sized machine shops that often lack sophisticated digital storefronts. This capital-light approach allows the company to scale without owning the physical manufacturing equipment.
The company serves diverse high-growth sectors including aerospace, defense, and medical devices, providing cloud-based tools like Workcenter and Teamspace to manage production workflows. Investors may find additional insights on sector-specific valuation trends by visiting ValueRay. Xometry was founded in 2013 and is headquartered in North Bethesda, Maryland.
- AI-powered marketplace revenue grows through increased buyer and supplier adoption
- Gross margins expand as proprietary pricing algorithms optimize transaction spreads
- International expansion in Europe and Asia drives long-term scale
- Thomasnet advertising revenue stabilizes high-margin software and services segment
| Net Income: -51.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA 2.43 > 1.0 |
| NWC/Revenue: 21.55% < 20% (prev 42.73%; Δ -21.18% < -1%) |
| CFO/TA 0.03 > 3% & CFO 24.8m > Net Income -51.9m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.78 > 1.5 & < 3 |
| Outstanding Shares: last quarter (51.9m) vs 12m ago 3.13% < -2% |
| Gross Margin: 39.27% > 18% (prev 39.05%; Δ 0.23% > 0.5%) |
| Asset Turnover: 103.6% > 50% (prev 83.15%; Δ 20.43% > 0%) |
| Interest Coverage Ratio: -9.87 > 6 (EBIT TTM -47.7m / Interest Expense TTM 4.83m) |
| A: 0.22 (Total Current Assets 364.1m - Total Current Liabilities 204.4m) / Total Assets 740.3m |
| B: -0.59 (Retained Earnings -437.3m / Total Assets 740.3m) |
| C: -0.07 (EBIT TTM -47.7m / Avg Total Assets 715.2m) |
| D: 0.62 (Book Value of Equity 282.0m / Total Liabilities 457.1m) |
| Altman-Z'' = -0.31 = B |
| DSRI: 1.08 (Receivables 119.7m/85.5m, Revenue 740.8m/573.8m) |
| GMI: 0.99 (GM 39.05% / 39.27%) |
| AQI: 0.92 (AQ_t 0.40 / AQ_t-1 0.44) |
| SGI: 1.29 (Revenue 740.8m / 573.8m) |
| TATA: -0.10 (NI -51.9m - CFO 24.8m) / TA 740.3m) |
| Beneish M = -2.81 (Cap -4..+1) = A |
As of June 12, 2026, the stock is trading at USD 86.15 with a total of 672,998 shares traded.
Over the past week, the price has changed by +4.17%,
over one month by +6.71%,
over three months by +103.52% and
over the past year by +154.73%.
Xometry has received a consensus analysts rating of 3.90. Therefore, it is recommended to buy XMTR.
- StrongBuy: 4
- Buy: 3
- Hold: 2
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 85.1 | -1.2% |
P/E Forward = 107.5269
P/S = 6.0153
P/B = 16.1945
Revenue TTM = 740.8m USD
EBIT TTM = -47.7m USD
EBITDA TTM = -27.5m USD
Long Term Debt = 242.7m USD (from longTermDebt, last quarter)
Short Term Debt = 87.7m USD (from shortTermDebt, last quarter)
Debt = 351.5m USD (from shortLongTermDebtTotal, last quarter) + Leases 11.7m
Net Debt = 127.5m USD (calculated: Debt 351.5m - CCE 224.0m)
Enterprise Value = 4.58b USD (4.46b + Debt 351.5m - CCE 224.0m)
Interest Coverage Ratio = -9.87 (Ebit TTM -47.7m / Interest Expense TTM 4.83m)
EV/FCF = -435.8x (Enterprise Value 4.58b / FCF TTM -10.5m)
FCF Yield = -0.23% (FCF TTM -10.5m / Enterprise Value 4.58b)
FCF Margin = -1.42% (FCF TTM -10.5m / Revenue TTM 740.8m)
Net Margin = -7.01% (Net Income TTM -51.9m / Revenue TTM 740.8m)
Gross Margin = 39.27% ((Revenue TTM 740.8m - Cost of Revenue TTM 449.9m) / Revenue TTM)
Gross Margin QoQ = 38.26% (prev 39.10%)
Tobins Q-Ratio = 6.19 (Enterprise Value 4.58b / Total Assets 740.3m)
Interest Expense / Debt = 1.38% (Interest Expense 4.83m / Debt 351.5m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -37.7m (EBIT -47.7m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.78 (Total Current Assets 364.1m / Total Current Liabilities 204.4m)
Debt / Equity = 1.25 (Debt 351.5m / totalStockholderEquity, last quarter 282.0m)
Debt / EBITDA = -4.64 (negative EBITDA) (Net Debt 127.5m / EBITDA -27.5m)
Debt / FCF = -12.12 (negative FCF - burning cash) (Net Debt 127.5m / FCF TTM -10.5m)
Total Stockholder Equity = 275.0m (last 4 quarters mean from totalStockholderEquity)
RoA = -7.26% (Net Income -51.9m / Total Assets 740.3m)
RoE = -18.89% (Net Income TTM -51.9m / Total Stockholder Equity 275.0m)
RoCE = -9.22% (EBIT -47.7m / Capital Employed (Equity 275.0m + L.T.Debt 242.7m))
RoIC = -6.43% (negative operating profit) (NOPAT -37.7m / Invested Capital 586.6m)
WACC = 14.57% (E(4.46b)/V(4.81b) * Re(15.63%) + D(351.5m)/V(4.81b) * Rd(1.38%) * (1-Tc(0.21)))
Discount Rate = 15.63% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 95.56 | Cagr: 3.45%
[DCF] Fair Price = unknown (Cash Flow -10.5m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 2.01 | # QB: 2
Revenue Correlation: 99.57 | Revenue CAGR: 22.14% | SUE: 4.0 | # QB: 5
EPS current Quarter (2026-06-30): EPS=0.15 | Chg30d=+11.96% | Revisions=+27% | Analysts=8
EPS next Quarter (2026-09-30): EPS=0.20 | Chg30d=-2.67% | Revisions=-17% | Analysts=8
EPS current Year (2026-12-31): EPS=0.71 | Chg30d=+5.74% | Revisions=+27% | GrowthEPS=+86.7% | GrowthRev=+27.6%
EPS next Year (2027-12-31): EPS=1.25 | Chg30d=+7.47% | Revisions=+27% | GrowthEPS=+76.0% | GrowthRev=+19.3%
[Analyst] Revisions Ratio: +27%